Inventor · disambiguated record
Yoichi Nishikawa
Also filed as: NISHIKAWA YOICHI
11 granted patents·1 pending application·22 citations·filing 2014–2023
85Inventor score
Files withTAKEDA PHARMACEUTICALS CO6CARDURION PHARMACEUTICALS LLC2TAKEDA PHARMACEUTICAL2EISAI R&D MAN CO LTD1SYSMEX CORP1
Top patents by PatentIndex Score
12 records- 0191US10543212B2Substituted amines for treating cardiac diseasesCARDURION PHARMACEUTICALS LLC·Filed 2018·Granted Jan 28, 2020·10 cites·11 claims
- 0282US9346776B2Fused heterocyclic compoundTAKEDA PHARMACEUTICAL·Filed 2015·Granted May 24, 2016·4 cites·3 claims
- 0376US9428470B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Aug 30, 2016·2 cites·3 claims
- 0476US9120777B2Heterocyclic compoundTAKEDA PHARMACEUTICAL·Filed 2014·Granted Sep 1, 2015·3 cites·10 claims
- 0575US9975903B2Condensed heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted May 22, 2018·2 cites·11 claims
- 0674US10017487B2Fused heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Jul 10, 2018·1 cites·16 claims
- 0761US2023408497A1Labeled polypeptide, modified polypeptide, production method for these polypeptides, reagent containing these polypeptides, and measurement method for target substanceSYSMEX CORP·Filed 2023·Application pending·0 cites
- 0855US11197858B2Substituted amines for treating cardiac diseasesCARDURION PHARMACEUTICALS LLC·Filed 2020·Granted Dec 14, 2021·0 cites·8 claims
- 0948US12253526B2Fluorescent dye and use thereofEISAI R&D MAN CO LTD·Filed 2021·Granted Mar 18, 2025·0 cites·20 claims
- 1048US9751878B2Tetrahydronaphthyridine somatostatin receptor 5 antagonistsTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Sep 5, 2017·0 cites·9 claims
- 1146US10023544B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Jul 17, 2018·0 cites·8 claims
- 1245US9969705B2Fused heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted May 15, 2018·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Yoichi Nishikawa files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →